Innovative Technologies Supporting Body Oxygen Through Life’s Challenges and Ageing

Clinically Validated

Superior bioavailability and pharmacodynamics demonstrated in clinical studies

Patent Protected

Technology, product applications and clinical data are licensed from Lycotec.com

Tissue oxygen decline One of the Leading preventive health challenges

Tissue oxygen concentration gradually reduces with ageing. Stress, negative lifestyle factors and diseases can accelerate this process.

The reduction in tissue O2, even on a subclinical level, may contribute to a decline of organ functions, reduces body adaptive responses and increases its susceptibility to the development to various pathological conditions.

Oxygenation of our body in ageing

Lycopharma products support body oxygen through life’s challenges and ageing.

Oxygen transport to body tissues

Why do our tissues develop oxygen deficiency?

Our products aim to support tissue oxygenation, immunity and healthy ageing

Scientific Advisory Board

The Lycopharma scientific advisory board, comprised of medical doctors, nutritionists and scientists, helps guide the company around the latest research and product innovation

Ivan M Petyaev
MD, PhD

Cambridge
United Kingdom

Dennis Sandris Nielsen
Professor, PhD

University of Copenhagen
Denmark

Wolfram Doehner
Professor, MD, PhD, FESC

Charite Virchow-Klinikum
Berlin, Germany

IK-Kyung Jang
Professor, MD, PhD

Massachusetts General Hospital
Boston USA

Alain Vuylsteke
MD, FRCA, FFICM

Royal Papworth Hospital
United Kingdom